Day: June 12, 2024

RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology

DURHAM, N.C. and WARSAW, Ind., June 12, 2024 /PRNewswire/ -- RevelAi Health and Zimmer Biomet Holdings, Inc. (NYSE and SIX:...

Positive Data from IceCure’s Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function

ICESECRET interim results, as previously announced, demonstrated ProSense® to be safe and effective in treating kidney tumors with 89.5% recurrence-free...

error: Content is protected !!